STOCK TITAN

[Form 4] Arteris, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Arteris, Inc. (AIP) insider Moll Laurent R, Chief Operating Officer and director, reported stock dispositions on 09/02/2025. The Form 4 shows three sales executed at $8.9417 per share: 868 shares, 17,264 shares and 24,560 shares. The filings show remaining beneficial ownership after each sale of 441,203; 423,939; and 399,379 shares, respectively. The Form states the shares were sold to satisfy the reporting person’s tax liability arising from the release of restricted stock units.

The Form 4 was signed by an attorney-in-fact on 09/03/2025. The disclosure documents the officer’s routine tax-related stock withholding and satisfies Section 16 reporting obligations.

Arteris, Inc. (AIP): l’insider Moll Laurent R, Chief Operating Officer e amministratore, ha comunicato cessioni di azioni in data 02/09/2025. Il Modulo 4 indica tre vendite al prezzo di 8,9417 $ per azione: 868 azioni, 17.264 azioni e 24.560 azioni. Dopo ciascuna operazione, la proprietà beneficiaria residua risulta pari a 441.203; 423.939; e 399.379 azioni, rispettivamente. Il documento specifica che le azioni sono state vendute per soddisfare l’obbligo fiscale della reporting person derivante dalla liberazione di restricted stock units.

Il Modulo 4 è stato firmato da un procuratore il 03/09/2025. La divulgazione descrive una trattenuta fiscale ordinaria su azioni e adempie agli obblighi di segnalazione ai sensi della Sezione 16.

Arteris, Inc. (AIP): la insider Moll Laurent R, directora de operaciones y miembro del consejo, informó disposiciones de acciones el 02/09/2025. El Formulario 4 muestra tres ventas ejecutadas a 8,9417 $ por acción: 868 acciones, 17.264 acciones y 24.560 acciones. Los registros indican la tenencia beneficiaria restante tras cada venta: 441.203; 423.939; y 399.379 acciones, respectivamente. El formulario precisa que las acciones se vendieron para cubrir la obligación fiscal de la persona informante derivada de la liberación de unidades restringidas de acciones.

El Formulario 4 fue firmado por un apoderado el 03/09/2025. La divulgación documenta una retención fiscal rutinaria sobre acciones y cumple las obligaciones de reporte según la Sección 16.

Arteris, Inc. (AIP)의 내부자 몰 로랑 R(최고운영책임자 겸 이사)이 2025-09-02에 주식 처분을 신고했습니다. Form 4에는 주당 8.9417달러에 실행된 세 건의 매도가 기록되어 있습니다: 868주, 17,264주, 24,560주. 각 매도 후 남은 수익적 소유주 보유 주식수는 각각 441,203주, 423,939주, 399,379주로 표시되어 있습니다. 해당 서류는 제한 주식 단위의 해제로 발생한 신고자의 세금 부담을 충당하기 위해 주식을 매도했다고 명시하고 있습니다.

Form 4는 2025-09-03에 대리인이 서명했습니다. 이 공시는 임원에 대한 통상적인 세금 관련 주식 원천징수를 문서화하며 섹션 16의 보고 의무를 충족합니다.

Arteris, Inc. (AIP) : l'initié Moll Laurent R, directeur des opérations et administrateur, a déclaré des cessions d'actions le 02/09/2025. Le formulaire 4 fait état de trois ventes exécutées à 8,9417 $ par action : 868 actions, 17 264 actions et 24 560 actions. Les dossiers indiquent la détention bénéficiaire restante après chaque vente : 441 203 ; 423 939 ; et 399 379 actions, respectivement. Le formulaire précise que les actions ont été vendues pour couvrir l'obligation fiscale de la personne déclarante résultant de la libération d'unités d'actions restreintes.

Le formulaire 4 a été signé par un mandataire le 03/09/2025. Cette divulgation documente une retenue fiscale routinière liée aux actions de l'officier et satisfait aux obligations de déclaration au titre de la Section 16.

Arteris, Inc. (AIP): Insider Moll Laurent R, Chief Operating Officer und Direktor, meldete Aktienveräußerungen am 02.09.2025. Das Formular 4 weist drei Verkäufe zum Kurs von 8,9417 $ je Aktie aus: 868 Aktien, 17.264 Aktien und 24.560 Aktien. Nach den jeweiligen Verkäufen verbleibt ein wirtschaftliches Eigentum von 441.203; 423.939; bzw. 399.379 Aktien. Im Formular heißt es, die Aktien seien verkauft worden, um die Steuerverpflichtung der meldenden Person infolge der Freigabe von Restricted Stock Units zu erfüllen.

Das Formular 4 wurde am 03.09.2025 von einem Bevollmächtigten unterzeichnet. Die Offenlegung dokumentiert die routinemäßige steuerbedingte Aktieneinbehaltung des Managers und erfüllt die Meldepflichten nach Abschnitt 16.

Positive
  • Timely SEC disclosure of insider transactions under Section 16 is provided
  • Sales explicitly identified as tax-withholding related to restricted stock unit releases, clarifying purpose
Negative
  • None.

Insights

TL;DR: Routine RSU tax-withholding sales by an officer; no new material corporate developments disclosed.

The filing documents three open-market dispositions at the same price, explicitly to cover tax liabilities from RSU vesting. This pattern is consistent with standard tax-withholding mechanics and does not on its face indicate a change in control or liquidity event. Investors should note the post-transaction beneficial ownership levels: 441,203; 423,939; and 399,379 shares, which provide context on the officer's remaining stake.

TL;DR: Disclosure adheres to Section 16 timing and identifies the transaction as tax-related; governance processes appear followed.

The Form 4 clearly states the transaction code and the tax-withholding purpose, and it was signed by an attorney-in-fact, indicating executed proxy authorization. The filing shows timely reporting and transparency around insider compensation-related dispositions, a routine governance occurrence rather than a governance concern.

Arteris, Inc. (AIP): l’insider Moll Laurent R, Chief Operating Officer e amministratore, ha comunicato cessioni di azioni in data 02/09/2025. Il Modulo 4 indica tre vendite al prezzo di 8,9417 $ per azione: 868 azioni, 17.264 azioni e 24.560 azioni. Dopo ciascuna operazione, la proprietà beneficiaria residua risulta pari a 441.203; 423.939; e 399.379 azioni, rispettivamente. Il documento specifica che le azioni sono state vendute per soddisfare l’obbligo fiscale della reporting person derivante dalla liberazione di restricted stock units.

Il Modulo 4 è stato firmato da un procuratore il 03/09/2025. La divulgazione descrive una trattenuta fiscale ordinaria su azioni e adempie agli obblighi di segnalazione ai sensi della Sezione 16.

Arteris, Inc. (AIP): la insider Moll Laurent R, directora de operaciones y miembro del consejo, informó disposiciones de acciones el 02/09/2025. El Formulario 4 muestra tres ventas ejecutadas a 8,9417 $ por acción: 868 acciones, 17.264 acciones y 24.560 acciones. Los registros indican la tenencia beneficiaria restante tras cada venta: 441.203; 423.939; y 399.379 acciones, respectivamente. El formulario precisa que las acciones se vendieron para cubrir la obligación fiscal de la persona informante derivada de la liberación de unidades restringidas de acciones.

El Formulario 4 fue firmado por un apoderado el 03/09/2025. La divulgación documenta una retención fiscal rutinaria sobre acciones y cumple las obligaciones de reporte según la Sección 16.

Arteris, Inc. (AIP)의 내부자 몰 로랑 R(최고운영책임자 겸 이사)이 2025-09-02에 주식 처분을 신고했습니다. Form 4에는 주당 8.9417달러에 실행된 세 건의 매도가 기록되어 있습니다: 868주, 17,264주, 24,560주. 각 매도 후 남은 수익적 소유주 보유 주식수는 각각 441,203주, 423,939주, 399,379주로 표시되어 있습니다. 해당 서류는 제한 주식 단위의 해제로 발생한 신고자의 세금 부담을 충당하기 위해 주식을 매도했다고 명시하고 있습니다.

Form 4는 2025-09-03에 대리인이 서명했습니다. 이 공시는 임원에 대한 통상적인 세금 관련 주식 원천징수를 문서화하며 섹션 16의 보고 의무를 충족합니다.

Arteris, Inc. (AIP) : l'initié Moll Laurent R, directeur des opérations et administrateur, a déclaré des cessions d'actions le 02/09/2025. Le formulaire 4 fait état de trois ventes exécutées à 8,9417 $ par action : 868 actions, 17 264 actions et 24 560 actions. Les dossiers indiquent la détention bénéficiaire restante après chaque vente : 441 203 ; 423 939 ; et 399 379 actions, respectivement. Le formulaire précise que les actions ont été vendues pour couvrir l'obligation fiscale de la personne déclarante résultant de la libération d'unités d'actions restreintes.

Le formulaire 4 a été signé par un mandataire le 03/09/2025. Cette divulgation documente une retenue fiscale routinière liée aux actions de l'officier et satisfait aux obligations de déclaration au titre de la Section 16.

Arteris, Inc. (AIP): Insider Moll Laurent R, Chief Operating Officer und Direktor, meldete Aktienveräußerungen am 02.09.2025. Das Formular 4 weist drei Verkäufe zum Kurs von 8,9417 $ je Aktie aus: 868 Aktien, 17.264 Aktien und 24.560 Aktien. Nach den jeweiligen Verkäufen verbleibt ein wirtschaftliches Eigentum von 441.203; 423.939; bzw. 399.379 Aktien. Im Formular heißt es, die Aktien seien verkauft worden, um die Steuerverpflichtung der meldenden Person infolge der Freigabe von Restricted Stock Units zu erfüllen.

Das Formular 4 wurde am 03.09.2025 von einem Bevollmächtigten unterzeichnet. Die Offenlegung dokumentiert die routinemäßige steuerbedingte Aktieneinbehaltung des Managers und erfüllt die Meldepflichten nach Abschnitt 16.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Moll Laurent R

(Last) (First) (Middle)
C/O ARTERIS, INC.
900 E. HAMILTON AVE., SUITE 300

(Street)
CAMPBELL CA 95008

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/02/2025 S(1) 868 D $8.9417 441,203 D
Common Stock 09/02/2025 S(1) 17,264 D $8.9417 423,939 D
Common Stock 09/02/2025 S(1) 24,560 D $8.9417 399,379 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares sold to satisfy the Reporting Person's tax liability arising as a result of the release of restricted stock units.
Remarks:
/s/ Paul Alpern, as Attorney-in-Fact for Moll Laurent R 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Moll Laurent R report on Form 4 for Arteris (AIP)?

The Form 4 reports three sales on 09/02/2025 of 868, 17,264, and 24,560 shares at $8.9417 per share.

Why were the shares sold by the reporting person?

The Form 4 states the shares were sold to satisfy the reporting person’s tax liability arising from the release of restricted stock units.

What were the reporting person’s beneficial holdings after the sales?

The filing lists beneficial ownership after the reported transactions as 441,203, 423,939, and 399,379 shares respectively.

When was the Form 4 signed and by whom?

The Form 4 was signed by Paul Alpern, as Attorney-in-Fact for Moll Laurent R on 09/03/2025.

Does the Form 4 indicate any derivatives or option exercises?

No. Table II for derivative securities contains no transactions; only non-derivative common stock sales are reported.
Arteris, Inc.

NASDAQ:AIP

AIP Rankings

AIP Latest News

AIP Latest SEC Filings

AIP Stock Data

377.03M
29.50M
30.79%
47.8%
2.57%
Semiconductors
Semiconductors & Related Devices
Link
United States
CAMPBELL